European Parliament Passes Pharmaceutical Regulatory Reform

Law360, New York (December 17, 2003, 12:00 AM EST) -- The European Parliament adopted sweeping new legislation Wednesday aimed at standardizing regulatory data protection for drugs across the European Union.

Under intense pressure from lobbyists for research-based and generic drug makers, the European Parliament reached a compromise for regulatory data protection known as “8+2+1,” under which new drugs will receive 10 years of protection from generic competition, including eight years of data protection, plus an additional year for new uses.

A final approval of the new regulatory environment by European Union ministers is expected in the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.